Willcocks receives funding to develop MR biomarkers of bone quality for individuals with Duchenne Muscular Dystrophy July 19, 2021
Willcocks receives funding to develop MR biomarkers of bone quality for individuals with Duchenne Muscular Dystrophy July 19, 2021